Thermal management composites and scaffolds for heat-generating implantable electronic devices made from the thermal management composites are provided. The composite materials are cytocompatible, porous materials that include hexagonal boron nitride particles dispersed in an elastomeric polymer binder.

Thermal management composites and scaffolds for heat-generating implantable electronic devices made from the thermal management composites are provided. The composite materials are cytocompatible, porous materials that include hexagonal boron nitride particles dispersed in an elastomeric polymer binder.

The present invention relates to the field of functional materials for medical use, and particularly to a biomimetic bone composite material, a preparation method and uses thereof. The biomimetic bone composite material provided by the invention is prepared from the raw material containing the following components: gelatin and/or collagen, hydroxyapatite and a silicon source. The present invention also provides a preparation method of the composite material and uses thereof in preparing bone repair materials. The highly biomimetic composite material with fibrous network structure prepared by the present invention can simulate the microenvironment similar to natural bone for cells, meet the biological requirements of bone tissue engineering, and is expected to become an ideal bioactive scaffold for bone repair.

The present invention relates to the field of functional materials for medical use, and particularly to a biomimetic bone composite material, a preparation method and uses thereof. The biomimetic bone composite material provided by the invention is prepared from the raw material containing the following components: gelatin and/or collagen, hydroxyapatite and a silicon source. The present invention also provides a preparation method of the composite material and uses thereof in preparing bone repair materials. The highly biomimetic composite material with fibrous network structure prepared by the present invention can simulate the microenvironment similar to natural bone for cells, meet the biological requirements of bone tissue engineering, and is expected to become an ideal bioactive scaffold for bone repair.

The present disclosure is directed to a composite implant for the sustained release of a therapeutic agent from a hydrogel matrix. The hydrogel matrix may be a cross-linked bioerodible polyethylene glycol (PEG) hydrogel with a therapeutic complex dispersed within the cross-linked bioerodible PEG hydrogel. The therapeutic complex may include a therapeutic agent in association with mesoporous silica particles. The composite implant is configured to be delivered to or implanted into an eye of a subject or patient. The composite implant may be used treat ocular disease in a subject or patient. Ocular diseases may be selected from at least one of neovascular age related macular degeneration (AMD), diabetic macular edema, or macular edema following retinal vein occlusion.

Temporary and/or disposable device that can be implanted in the human body, including a biocompatible material implantable in the human body and including a plastic material, wherein the material includes a pharmaceutical or medical substance including at least one antibiotic and a radio-opacifying agent; method for the obtainment of such device and thread of 3D-printing material for the obtainment of such device.

Thermal management composites and scaffolds for heat-generating implantable electronic devices made from the thermal management composites are provided. The composite materials are cytocompatible, porous materials that include hexagonal boron nitride particles dispersed in an elastomeric polymer binder.

A solidifying prepolymeric implant composition comprising a biocompatible prepolymer and an optional filler. One such implant composition is a polyurethane implant composition comprising an isocyanate, such as hydroxymethylenediisocyanate (HMDI) and an alcohol, such as polycaprolactonediol (PCL diol). The compositions of the invention are useful for improving bone structure in patients by applying the solidifying implant composition to bone, reinforcing bone structure, improving load bearing capacity and/or aiding healing of microfractures.

A solidifying prepolymeric implant composition comprising a biocompatible prepolymer and an optional filler. One such implant composition is a polyurethane implant composition comprising an isocyanate, such as hydroxymethylenediisocyanate (HMDI) and an alcohol, such as polycaprolactonediol (PCL diol). The compositions of the invention are useful for improving bone structure in patients by applying the solidifying implant composition to bone, reinforcing bone structure, improving load bearing capacity and/or aiding healing of microfractures.

The present invention relates to the field of implants. In particular, the present invention relates to an implant for tissue reconstruction which comprises a scaffold structure that includes a void system for the generation of prevascularized connective tissue with void spaces for cell and/or tissue transplantation. Moreover, the present invention relates to a method of manufacturing such an implant, to the internal architecture of such an implant, to a removal tool for mechanical removal of space-occupying structures from such an implant, to a kit comprising such an implant and such a removal tool, to a removal device for the removal of superparamagnetic or ferromagnetic space-occupying structures from such an implant, as well as to a guiding device for providing feedback to a surgeon during the procedure of introducing transplantation cells into the void spaces generated upon removal of space-occupying structures from such an implant.